Tecan and CellSpring, a biotech spin-out from ETH Zurich, have announced a co-marketing agreement to automate the 3D Bloom^® platform on a Freedom EVO^® workstation.

This latest collaboration will further extend Tecan’s automated 3D cell culture portfolio, allowing scientists to take advantage of a high throughput technology with an extended cell viability period of at least seven days in the assay matrix. 

The adaptive 3D Bloom Biopolymer Platform is compatible with all cell types and is ideal for both mono and co-culture assays. 3D microtissues can be prepared in microplate format within minutes, and analysis carried out while still in the culture matrix. Kevin Moore, Manager of Liquid Handling Products and Application Management, commented: “As a leader in the field of automated 3D cell culture, Tecan is delighted to be working with CellSpring to implement its microplate-based 3D Bloom platform on the Freedom EVO. This will allow scientists to benefit from straightforward, high throughput automation of a 3D cell culture process offering long-term cell viability.”

Dr Chris Millan, Chief Technology Officer at CellSpring, added: “CellSpring is excited to partner with Tecan to bring automated, simple 3D cell culture solutions to customers. The benefits of our 3D Bloom Platform – versatility and reliability – are now available at scale using the Freedom EVO.”

more about tecan

more news from tecan